Article

Bausch + Lomb, Leica form partnership

Leica Microsystems and Bausch + Lomb have announced that Bausch + Lomb will distribute Leica ophthalmic surgical microscopes and accessories in select markets.

 

Aliso Viejo, CA and Wetzlar, Germany-Leica Microsystems and Bausch + Lomb have announced that Bausch + Lomb will distribute Leica ophthalmic surgical microscopes and accessories in select markets across Europe, the United States, India, and Latin America beginning this month.

The partnership combines the strength of Leica’s ophthalmic microscopes with Bausch + Lomb’s global commercial infrastructure, while expanding Bausch + Lomb’s offerings for ophthalmic surgeons. Under the agreement, Bausch + Lomb can now offer Leica Microsystems’ ophthalmic portfolio, which ranges from routine cataract microscopes to high-end retinal systems. According to the contract, this relationship may be expanded over time.

“We are excited to offer Leica surgical microscopes, as they enhance our ability to offer a ‘one-stop shop’ for an ophthalmic surgeons’ needs, while also accelerating the growth of our business,” John Barr, executive vice president and president, Bausch + Lomb Global Surgical, commented.

“Through this partnership with Bausch + Lomb, we will be able to provide more patients around the world with better access to our world-leading imaging systems,” added Eoghan O’Lionaird, president, Leica Microsystems.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
© 2025 MJH Life Sciences

All rights reserved.